In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Astringent Final Rule Contains Revised Labeling, Small Package Exemptions

This article was originally published in The Rose Sheet

Executive Summary

The Skin Protectant Astringent direct final rule includes minor labeling changes and small packaging exemptions to bring the astringent portion of the Skin Protectant Monograph in line with the rest of the rule, FDA says. The agency published the direct final rule in the Federal Register June 13
Advertisement

Related Content

Astringent rule
Astringent rule
Skin Protectant Final Rule Allows Cross-Monograph Ingredient Combinations
Skin Protectant Final Rule Allows Cross-Monograph Ingredient Combinations
Advertisement
UsernamePublicRestriction

Register

RS011274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel